Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors

NCT06195384 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

BIOLOGICAL: Neoantigen mRNA Vaccine

Sponsor

Second Affiliated Hospital of Guangzhou Medical University